Background Despite current medical and surgical therapy, infants with symptomatic congenital mitral stenosis (CMS) continue to have high rates of morbidity and mortality. Catheter balloon dilation has been successful in relieving symptoms in a few older children with CMS but has not been evaluated in infants.
Methods and Results We reviewed the records of 85 infants with CMS to assess severity of CMS, associated cardiac lesions, echocardiagraphic morphological appearance of the mitral valve, treatment, and outcome. There were five valve morphologies identified: "typical" hypoplastic mitral valve with symmetric papillary muscles (SYMM, 52%), supravalvar mitral ring (SVMR, 20%), double-orifice mitral valve (DOMV, 11%), hypoplastic mitral valve with asymmetric papillary muscles (ASYMM, 8%), and parachute mitral valve (PARA, 8%). Of the 85 infants, 31 (36%) were severely symptomatic, requiring intervention within the first 2 years. Balloon dilation was performed in 18 infants (age, 8.7±5.7 months; weight, 5.9±1.9 kg) and valve surgery in 13 (age, 10.9±5.9 months; weight, 6.7±2.1 kg). Balloon dilation decreased the peak transmitral gradient (LAa-LVED) >30% in 15 of 18 initial attempts, from 20.3±8.2 to 10.9±4.9 mm Hg (P<.001), and the mitral valve area increased from 0.7±0.3 to 1.0±0.5 cm2/M2 (n=10, P=.01). No infants died during the initial balloon dilation, although 2 of 3 died during a repeat procedure for restenosis. Other complications included significant mitral regurgitation in 7 of 18 patients (39%), 4 of whom had SVMR. Of the 18 infants, 8 (44%) had persistent symptomatic improvement at a mean follow-up of 14 months (range, 2 to 32 months). The 2-year survival after balloon dilation was 70%; 40% remained free of repeat intervention. Mitral valve surgery in 13 infants consisted of SVMR resections in 7, mitral valve replacements in 4, and LA-to-LV aortic valved homografts in 2. The operative mortality was 30%. Sustained improvement occurred in 8 (6 with SVMR) at 11 to 62 months of follow-up (mean, 30 months), with a 2-year survival of 60%.
Conclsuions Infants with severe CMS have 2-year mortality rates approaching 40% regardless of treatment modality. Balloon dilation significantly reduces the transmitral gradient in the majority, but symptomatic improvement persists in only 40%. Procedure-related mortality was associated with repeat balloon dilation in patients with left ventricular hypoplasia. Balloon dilation of "typical" CMS can provide symptomatic relief in many infants, allowing postponement of valve replacement, although infants with SVMR (Fig 3) . Death related to sepsis and progressive congestive heart failure occurred in two infants within 3 months of balloon dilation. Severe tricuspid stenosis and right heart failure were evident in one and significant aortic stenosis and coarctation in the other. A repeat balloon dilation for recurrence of stenosis within 4 months of initial balloon dilation was undertaken in three infants, two of whom died within 24 hours related to complications associated with inflation of a large dilation balloon in a small left ventricle. The causes of death were left ventricular perforation and cardiac tamponade in one infant and sustained bradycardia/cardiac arrest in the other. In the third patient, a successful redilation was accomplished, and persistent clinical improvement was evident at 17 months' follow-up.
MVR was necessary in five infants within 2 months of the balloon dilation for persistent symptoms of CMS and/or iatrogenic mitral regurgitation; four of these five had associated SVMR. In another (patient 9), MVR was required 10 months after balloon dilation because of persistent mitral stenosis with progressive mitral regurgitation. Of the 6 patients who had MVR, three (patients 8, 12, and 13) were alive and asymptomatic at follow-up (10, 25, and 27 months); another (patient 9) had progressive congestive heart failure with systemic pulmonary hypertension and underwent heart/lung transplant at 20 months' follow-up; another (patient 10) died at the time of repeat MVR 2.5 years after initial replacement, and the other (patient 11) died 2 months after MVR as a result of persistent pulmonary hypertension and right ventricular failure.
Complications of Balloon Dilation
Transient hemodynamic instability, including major bradycardia and hypotension, occurred in all infants. Immediate moderate or severe mitral regurgitation appeared in 22%, with late progression to moderate mitral regurgitation occurring in 17%. Immediate mild regurgitation occurred in 28%, with late progression to moderate regurgitation in one patient. In three patients (one severe, one moderate, one mild progressing to moderate regurgitation) echocardiographic evidence of a torn or flail leaflet after balloon dilation was evident. Transient second-and third-degree heart block occurred in 22% and venous thrombosis and cardiac arrest requiring inotropic support in 6% each. There were five deaths in this group, with an operative mortality of 30% and 2-year survival of 55% (Fig 3) . Of these, two occurred early during MVR (one with SVMR resection during the same procedure). There were three late deaths; two infants died of progressive congestive heart failure 1 and 5 months after surgery (LA-to-LV homograft in one and MVR in the other) and the other infant died suddenly 1 month after SVMR resection. Although not statistically significant, both operative (SVMR, 75% versus non-SVMR, 60%) and 2-year survival (SVMR, 75% versus non-SVMR, 40%) appear better for infants with SVMR than those with other anatomic forms of CMS.
Complications of Surgery
Both patients who had LA-to-LV aortic homografts placed required repeat operation within 2 weeks, one for aneurysmal dilation of the original homograft and the other for homograft stenosis associated with mediastinitis. One infant developed severe mitral regurgitation 1 week after SVMR resection and required MVR. Another infant developed third-degree heart block during MVR, requiring permanent pacemaker placement. The infant with SVMR who died suddenly at home required medical treatment for significant postoperative supraventricular tachycardia, which presumably contributed to his sudden death. parachute mitral valve had the least severe stenosis, as evidenced by the lowest mean Doppler transmitral gradient. These findings are consistent with those of Ruckman et al,'S who showed in an autopsy series that the asymmetric variant of CMS may be a forme fruste of parachute mitral valve and is associated with the longest longevity of any anatomic type. Significant mitral regurgitation occurred in <4% of infants with CMS and only in those with symmetric hypoplastic mitral valve. Only 3 of the 85 infants had isolated CMS, two with SYMM and the other with the asymmetric variant. Despite the strong association of left-sided obstructive lesions, subaortic stenosis and valvar aortic stenosis and coarctation, with CMS,12.16 the DOMV variant was more frequently associated with ventricular septal defect and atrial septal defect. In addition, parachute mitral valve was associated with Fallot's tetralogy and ASYMM with DORy. Management: Medicine Severity of mitral stenosis and associated cardiac lesions are major determinants of treatment and eventual outcome. 16 Among our infants with CMS, 60% had less severe stenosis requiring only medical management. Despite less severe mitral stenosis, 30% died in infancy as a result of associated cardiac lesions. Nearly 70% of the surviving infants have had follow-up Doppler evaluation of their transmitral gradient, with no evidence of progression of their stenosis. Because of the variability of timing of diagnosis and the large number of patients 
